These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 27585549)

  • 21. Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Okuyama Y; Oya K; Matsunaga S; Kishi T; Iwata N
    Neuropsychiatr Dis Treat; 2016; 12():3221-3236. PubMed ID: 28008259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: a meta-analysis of double-blind randomized placebo-controlled trials.
    Kishi T; Mukai T; Matsuda Y; Moriwaki M; Iwata N
    J Psychiatr Res; 2013 Nov; 47(11):1557-63. PubMed ID: 23899496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
    Behdani F; Hebrani P; Rezaei Ardani A; Rafee E
    Arch Iran Med; 2011 Jul; 14(4):270-5. PubMed ID: 21726104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Kishi T; Matsui Y; Matsuda Y; Katsuki A; Hori H; Yanagimoto H; Sanada K; Morita K; Yoshimura R; Shoji Y; Hagi K; Iwata N
    Pharmacopsychiatry; 2019 Feb; 52(2):52-62. PubMed ID: 29514360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
    Citrome L
    Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipsychotics for primary alcohol dependence: a systematic review and meta-analysis of placebo-controlled trials.
    Kishi T; Sevy S; Chekuri R; Correll CU
    J Clin Psychiatry; 2013 Jul; 74(7):e642-54. PubMed ID: 23945459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis.
    Sakuma K; Matsunaga S; Nomura I; Okuya M; Kishi T; Iwata N
    Psychopharmacology (Berl); 2018 Aug; 235(8):2303-2314. PubMed ID: 29785555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials.
    Correll CU; Rummel-Kluge C; Corves C; Kane JM; Leucht S
    Schizophr Bull; 2009 Mar; 35(2):443-57. PubMed ID: 18417466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topiramate's effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial.
    Chandradasa M; Champika L; de Silva S; Kuruppuarachchi KALA
    Trials; 2017 Sep; 18(1):435. PubMed ID: 28931411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia.
    Galling B; Vernon JA; Pagsberg AK; Wadhwa A; Grudnikoff E; Seidman AJ; Tsoy-Podosenin M; Poyurovsky M; Kane JM; Correll CU
    Acta Psychiatr Scand; 2018 Mar; 137(3):187-205. PubMed ID: 29431197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Iwata N
    J Psychiatr Res; 2013 Sep; 47(9):1143-9. PubMed ID: 23692933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT
    Hum Psychopharmacol; 2016 Jul; 31(4):286-95. PubMed ID: 27302211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zhu XM; Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Wang XP; Kulkarni J; Grigg J; Ning YP; Xiang YT
    Schizophr Res; 2018 Jul; 197():288-293. PubMed ID: 29395611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.
    Solmi M; Veronese N; Thapa N; Facchini S; Stubbs B; Fornaro M; Carvalho AF; Correll CU
    CNS Spectr; 2017 Oct; 22(5):415-426. PubMed ID: 28181901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjunctive Electroconvulsive Therapy for Schizophrenia: A Meta-analysis of Randomized Rater-Masked Controlled Trials [RETRACTED].
    Zheng W; Xiang YT; Tang YL; Xiang YQ; Li XB; Cao XL; Guo T; Liu ZR; Chiu HF; Ungvari GS; de Leon J
    J ECT; 2016 Aug; ():. PubMed ID: 27428477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis.
    Kishi T; Kafantaris V; Sunday S; Sheridan EM; Correll CU
    J Clin Psychiatry; 2012 Jun; 73(6):e757-66. PubMed ID: 22795216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials.
    Kishi T; Matsuda Y; Nakamura H; Iwata N
    J Psychiatr Res; 2013 Feb; 47(2):149-54. PubMed ID: 23131856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Oya K; Kishi T; Iwata N
    Hum Psychopharmacol; 2014 Sep; 29(5):483-91. PubMed ID: 25087702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial.
    Afshar H; Roohafza H; Mousavi G; Golchin S; Toghianifar N; Sadeghi M; Talaei M
    J Psychopharmacol; 2009 Mar; 23(2):157-62. PubMed ID: 18515465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.